Rigel Pharmaceuticals (RIGL) EBITDA Margin Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3,609.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,536.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -957.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 8,807.00 |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn | -374.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -374.00 |
| Dec 31, 2025 | 428.00 |
| Sep 30, 2025 | 1,550.00 |
| Jun 30, 2025 | 5,888.00 |
| Mar 31, 2025 | 4,754.00 |
| Dec 31, 2024 | 2,342.00 |
| Sep 30, 2024 | 4,128.00 |
| Jun 30, 2024 | 2,080.00 |
| Mar 31, 2024 | 2,522.00 |
| Dec 31, 2023 | 144.00 |
| Sep 30, 2023 | 6,625.00 |
| Jun 30, 2023 | 2,389.00 |
| Mar 31, 2023 | 10,811.00 |
| Dec 31, 2022 | 10,900.00 |
| Sep 30, 2022 | 972.00 |
| Jun 30, 2022 | 620.00 |
| Mar 31, 2022 | -20,846.00 |
| Dec 31, 2021 | -290.00 |
| Sep 30, 2021 | -1,690.00 |
| Jun 30, 2021 | 5,888.00 |
| Mar 31, 2021 | 1,383.00 |
| Dec 31, 2020 | 1,053.00 |
| Sep 30, 2020 | -1,723.00 |
| Jun 30, 2020 | 9,649.00 |
| Mar 31, 2020 | 18,329.00 |
| Dec 31, 2019 | -11,927.00 |
| Sep 30, 2019 | 44,321.00 |
| Jun 30, 2019 | 125,612.00 |
| Dec 31, 2018 | -57,795.00 |
| Sep 30, 2018 | 148,296.00 |
| Dec 31, 2017 | 111,087.00 |
| Sep 30, 2017 | -137,913.00 |
| Mar 31, 2017 | -10,275.00 |
| Dec 31, 2016 | -37,692.00 |
| Sep 30, 2016 | -55,258.00 |
| Jun 30, 2016 | 11,075.00 |
| Mar 31, 2016 | 48,820.00 |
| Jun 30, 2013 | 2,416.00 |
| Jun 30, 2012 | 379,867.00 |
| Sep 30, 2011 | -48,393.00 |
| Jun 30, 2011 | -551,202.00 |